More Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A news
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class ASSE: 600436

"ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD."Semi-annual Report for 2026

Aug 29, 2026 · Issued by Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Semi-annual Report for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A

  • "ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD."Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of the Company's 2025 Annual ReportAug 1
  • "ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD."Announcement on Departure of Directors and Senior Management MembersJul 30
  • "ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD."Announcement on Implementation of Dividend Distribution for 2025Jul 24
  • "ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD."Announcement on Abnormal Fluctuations in Stock TradingJul 18
All Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A news releases↗